Se connecter
Intranet
Thème

Biographie pas encore disponible.

Publications

2025
Emre Baspinar, Martina Simonti, Hadi Srour, Mathieu Desroches, Daniele Avitabile, Massimo Mantegazza , GABAergic neurons can facilitate the propagation of cortical spreading depolarization: experiments in mouse neocortical slices and a novel neural field computational model, PLoS Comput Biol . 2025 Jun 4;21(6):e1013099.
2025
Pizzamiglio L, Capitano F, Rusina E, Fossati G, Menna E, Léna I, Antonucci F, Mantegazza M., Neurodevelopmental defects in Dravet syndrome Scn1a+/− mice: Targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality, Neurobiol Dis. 2025 Apr;207:106853.
2025
Lisgaras C.P., de la Prida L.M., Bertram E., Cunningham M., Liu A.A., Gnatkovsky V., Balestrini S., de Curtis M., Galanopoulou A.S., Henshall D., Jacobs J., Jefferys J.G.R., Mantegazza M., Reschke C.R., Jiruska P. , The role of electroencephalography in epilepsy research-From seizures to interictal activity and comorbidities, Epilepsia . 2025 May;66(5):1374-1393. .
2024
Rusina E, Simonti M, Duprat F, Cestèle S, Mantegazza M, Voltage-gated sodium channels in genetic epilepsy: up and down of excitability., J Neurochem 2024 Dec; 168(12): 3872-3890.
2024
Capitano F, Kuchenbuch M, Lavigne J, Chaptoukaev H, Zuluaga MA, Lorenzi M, Nabbout R, Mantegazza M, Preictal dysfunctions of inhibitory interneurons paradoxically lead to their rebound hyperactivity and to low-voltage-fast onset seizures in Dravet syndrome., Proc Natl Acad Sci U S A 2024 Jun; 121(23): e2316364121.
2024
Jansen NA, Cestèle S, Marco SS, Schenke M, Stewart K, Patel J, Tolner EA, Brunklaus A, Mantegazza M, van den Maagdenberg AMJM, Brainstem depolarization-induced lethal apnea associated with gain-of-function SCN1AL263V is prevented by sodium channel blockade., Proc Natl Acad Sci U S A 2024 Apr; 121(14): e2309000121.
2024
Casillas-Espinosa PM, Wong JC, Grabon W, Gonzalez-Ramos A, Mantegazza M, Yilmaz NC, Patel M, Staley K, Sankar R, O'Brien TJ, Akman Ö, Balagura G, Numis AL, Noebels JL, Baulac S, Auvin S, Henshall DC, Galanopoulou AS, WONOEP appraisal: Targeted therapy development for early onset epilepsies., Epilepsia 2024 Nov; (): .
2024
Smith J, Richerson G, Kouchi H, Duprat F, Mantegazza M, Bezin L, Rheims S, Are we there yet? A critical evaluation of sudden and unexpected death in epilepsy models., Epilepsia 2024 Jan; 65(1): 9-25.
2023
Lopez L, De Waard S, Meudal H, Caumes C, Khakh K, Peigneur S, Oliveira-Mendes B, Lin S, De Waele J, Montnach J, Cestèle S, Tessier A, Johnson JP, Mantegazza M, Tytgat J, Cohen C, Béroud R, Bosmans F, Landon C, De Waard M, Structure-function relationship of new peptides activating human Nav1.1., Biomed Pharmacother 2023 Sep; 165(): 115173.
2023
Lemaire L, Desroches M, Krupa M, Mantegazza M, Idealized multiple-timescale model of cortical spreading depolarization initiation and pre-epileptic hyperexcitability caused by NaV1.1/SCN1A mutations., J Math Biol 2023 May; 86(6): 92.
2023
Matricardi S, Cestèle S, Trivisano M, Kassabian B, Leroudier N, Vittorini R, Nosadini M, Cesaroni E, Siliquini S, Marinaccio C, Longaretti F, Podestà B, Operto FF, Luisi C, Sartori S, Boniver C, Specchio N, Vigevano F, Marini C, Mantegazza M, Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication., Epilepsia 2023 May; 64(5): 1331-1347.
2023
Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F, Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum., Physiol Rev 2023 Jan; 103(1): 433-513.
2023
Scalmani P, Paterra R, Mantegazza M, Avoli M, de Curtis M, Involvement of GABAergic Interneuron Subtypes in 4-Aminopyridine-Induced Seizure-Like Events in Mouse Entorhinal Cortex in Vitro., J Neurosci 2023 Mar; 43(11): 1987-2001.
2022
Mantegazza M, Cestèle S, Predictive precision medicine efforts for voltage-gated sodium channel genetic variants., Brain 2022 Dec; 145(12): 4148-4150.
2022
Brunklaus A, Brünger T, Feng T, Fons C, Lehikoinen A, Panagiotakaki E, Vintan MA, Symonds J, Andrew J, Arzimanoglou A, Delima S, Gallois J, Hanrahan D, Lesca G, MacLeod S, Marjanovic D, McTague A, Nuñez-Enamorado N, Perez-Palma E, Scott Perry M, Pysden K, Russ-Hall SJ, Scheffer IE, Sully K, Syrbe S, Vaher U, Velayutham M, Vogt J, Weiss S, Wirrell E, Zuberi SM, Lal D, Møller RS, Mantegazza M, Cestèle S, The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications., Brain 2022 Nov; 145(11): 3816-3831.
2022
Mantegazza M, Auvin S, Barker-Haliski M, Katsarou AM, Kubova H, Galanopoulou AS, Semple B, Reid CA, A companion to the preclinical common data elements for rodent genetic epilepsy models. A report of the TASK3-WG1B: Paediatric and genetic models working group of the ILAE/AES joint translational TASK force., Epilepsia Open 2022 Aug; (): .
2022
Beretta S, Gritti L, Ponzoni L, Scalmani P, Mantegazza M, Sala M, Verpelli C, Sala C, Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K)., Mol Autism 2022 Jan; 13(1): 1.
2021
Chever O, Zerimech S, Scalmani P, Lemaire L, Pizzamiglio L, Loucif A, Ayrault M, Krupa M, Desroches M, Duprat F, Léna I, Cestèle S, Mantegazza M, Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels., J Clin Invest 2021 Nov; 131(21): .
2021
Mantegazza M, Cestèle S, Catterall WA, Sodium channelopathies of skeletal muscle and brain., Physiol Rev 2021 Oct; 101(4): 1633-1689.
2021
Lemaire L, Desroches M, Krupa M, Pizzamiglio L, Scalmani P, Mantegazza M, Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine., PLoS Comput Biol 2021 Jul; 17(7): e1009239.
2021
Alari V, Scalmani P, Ajmone PF, Perego S, Avignone S, Catusi I, Lonati PA, Borghi MO, Finelli P, Terragni B, Mantegazza M, Russo S, Larizza L, Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients., Int J Mol Sci 2021 May; 22(11): .
2021
Montnach J, De Waard S, Nicolas S, Burel S, Osorio N, Zoukimian C, Mantegazza M, Boukaiba R, Béroud R, Partiseti M, Delmas P, Marionneau C, De Waard M, Fluorescent- and tagged-protoxin II peptides: potent markers of the Nav 1.7 channel pain target., Br J Pharmacol 2021 Jul; 178(13): 2632-2650.
2020
Culotta L, Scalmani P, Vinci E, Terragni B, Sessa A, Broccoli V, Mantegazza M, Boeckers T, Verpelli C, SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex., J Neurosci 2020 Sep; 40(37): 7013-7026.
2020
Zerimech S, Chever O, Scalmani P, Pizzamiglio L, Duprat F, Mantegazza M, Cholinergic modulation inhibits cortical spreading depression in mouse neocortex through activation of muscarinic receptors and decreased excitatory/inhibitory drive., Neuropharmacology 2020 Apr; 166(): 107951.
2019
Mantegazza M, Broccoli V, SCN1A/NaV 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models., Epilepsia 2019 Dec; 60 Suppl 3(): S25-S38.
2019
Léna I, Mantegazza M, NaV1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age., Sci Rep 2019 Sep; 9(1): 12886.
2019
Marcuzzo S, Terragni B, Bonanno S, Isaia D, Cavalcante P, Cappelletti C, Ciusani E, Rizzo A, Regalia G, Yoshimura N, Ugolini GS, Rasponi M, Bechi G, Mantegazza M, Mantegazza R, Bernasconi P, Minati L, Hyperexcitability in Cultured Cortical Neuron Networks from the G93A-SOD1 Amyotrophic Lateral Sclerosis Model Mouse and its Molecular Correlates., Neuroscience 2019 Sep; 416(): 88-99.
2019
Salgueiro-Pereira AR, Duprat F, Pousinha PA, Loucif A, Douchamps V, Regondi C, Ayrault M, Eugie M, Stunault MI, Escayg A, Goutagny R, Gnatkovsky V, Frassoni C, Marie H, Bethus I, Mantegazza M, A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies., Neurobiol Dis 2019 May; 125(): 31-44.
2018
May P, Girard S, Harrer M, Bobbili DR, Schubert J, Wolking S, Becker F, Lachance-Touchette P, Meloche C, Gravel M, Niturad CE, Knaus J, De Kovel C, Toliat M, Polvi A, Iacomino M, Guerrero-López R, Baulac S, Marini C, Thiele H, Altmüller J, Jabbari K, Ruppert AK, Jurkowski W, Lal D, Rusconi R, Cestèle S, Terragni B, Coombs ID, Reid CA, Striano P, Caglayan H, Siren A, Everett K, Møller RS, Hjalgrim H, Muhle H, Helbig I, Kunz WS, Weber YG, Weckhuysen S, Jonghe P, Sisodiya SM, Nabbout R, Frances..., Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study., Lancet Neurol 2018 Aug; 17(8): 699-708.
2018
Castagnola S, Delhaye S, Folci A, Paquet A, Brau F, Duprat F, Jarjat M, Grossi M, Béal M, Martin S, Mantegazza M, Bardoni B, Maurin T, New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons., Front Mol Neurosci 2018 ; 11(): 342.
2017
Montani C, Ramos-Brossier M, Ponzoni L, Gritti L, Cwetsch AW, Braida D, Saillour Y, Terragni B, Mantegazza M, Sala M, Verpelli C, Billuart P, Sala C, The X-Linked Intellectual Disability Protein IL1RAPL1 Regulates Dendrite Complexity., J Neurosci 2017 Jul; 37(28): 6606-6627.
2017
Kapetis D, Sassone J, Yang Y, Galbardi B, Xenakis MN, Westra RL, Szklarczyk R, Lindsey P, Faber CG, Gerrits M, Merkies IS, Dib-Hajj SD, Mantegazza M, Waxman SG, Lauria G, Network topology of NaV1.7 mutations in sodium channel-related painful disorders., BMC Syst Biol 2017 Feb; 11(1): 28.
2017
Khalfallah O, Jarjat M, Davidovic L, Nottet N, Cestèle S, Mantegazza M, Bardoni B, Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis., Stem Cells 2017 Feb; 35(2): 374-385.
2014
Guerrini R, Marini C, Mantegazza M, Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models., Neurotherapeutics 2014 Apr; 11(2): 269-85.
2013
Cestèle S, Schiavon E, Rusconi R, Franceschetti S, Mantegazza M, Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects., Proc Natl Acad Sci U S A 2013 Oct; 110(43): 17546-51.
2013
Partemi S, Cestèle S, Pezzella M, Campuzano O, Paravidino R, Pascali VL, Zara F, Tassinari CA, Striano S, Oliva A, Brugada R, Mantegazza M, Striano P, Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death., Epilepsia 2013 Aug; 54(8): e112-6.
2013
Liautard C, Scalmani P, Carriero G, de Curtis M, Franceschetti S, Mantegazza M, Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome., Epilepsia 2013 Jul; 54(7): 1251-61.
2013
Cestèle S, Labate A, Rusconi R, Tarantino P, Mumoli L, Franceschetti S, Annesi G, Mantegazza M, Gambardella A, Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine., Epilepsia 2013 May; 54(5): 927-35.
2013
Verpelli C, Carlessi L, Bechi G, Fusar Poli E, Orellana D, Heise C, Franceschetti S, Mantegazza R, Mantegazza M, Delia D, Sala C, Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells., Front Cell Neurosci 2013 ; 7(): 175.
2013
Colombo E, Franceschetti S, Avanzini G, Mantegazza M, Phenytoin inhibits the persistent sodium current in neocortical neurons by modifying its inactivation properties., PLoS One 2013 ; 8(1): e55329.
2012
Goaillard JM, Groc L, Lévi S, Mantegazza M, Matifat F, Morel JL, Baron-Forster A, The 22nd ion channel meeting, september 2011, france., Channels (Austin) 2012 ; 6(3): 149-53.
2012
Bechi G, Scalmani P, Schiavon E, Rusconi R, Franceschetti S, Mantegazza M, Pure haploinsufficiency for Dravet syndrome Na(V)1.1 (SCN1A) sodium channel truncating mutations., Epilepsia 2012 Jan; 53(1): 87-100.
2010
Marini C, Mantegazza M, Na+ channelopathies and epilepsy: recent advances and new perspectives., Expert Rev Clin Pharmacol 2010 May; 3(3): 371-84.
2010
Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M, Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders., Lancet Neurol 2010 Apr; 9(4): 413-24.
2009
Riva D, Vago C, Pantaleoni C, Bulgheroni S, Mantegazza M, Franceschetti S, Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes., Am J Med Genet A 2009 Oct; 149A(10): 2339-45.
2009
Tang B, Dutt K, Papale L, Rusconi R, Shankar A, Hunter J, Tufik S, Yu FH, Catterall WA, Mantegazza M, Goldin AL, Escayg A, A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation., Neurobiol Dis 2009 Jul; 35(1): 91-102.
2009
Rusconi R, Combi R, Cestèle S, Grioni D, Franceschetti S, Dalprà L, Mantegazza M, A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: common mechanism in Nav1.1 related epilepsies?, Hum Mutat 2009 Jul; 30(7): E747-60.
2008
Cestèle S, Scalmani P, Rusconi R, Terragni B, Franceschetti S, Mantegazza M, Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel., J Neurosci 2008 Jul; 28(29): 7273-83.
2007
Rusconi R, Scalmani P, Cassulini RR, Giunti G, Gambardella A, Franceschetti S, Annesi G, Wanke E, Mantegazza M, Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ channel mutant., J Neurosci 2007 Oct; 27(41): 11037-46.
2007
Colosimo E, Gambardella A, Mantegazza M, Labate A, Rusconi R, Schiavon E, Annesi F, Cassulini RR, Carrideo S, Chifari R, Canevini MP, Canger R, Franceschetti S, Annesi G, Wanke E, Quattrone A, Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation., Epilepsia 2007 Sep; 48(9): 1691-1696.
2007
Avanzini G, Franceschetti S, Mantegazza M, Epileptogenic channelopathies: experimental models of human pathologies., Epilepsia 2007 ; 48 Suppl 2(): 51-64.
2006
Scalmani P, Rusconi R, Armatura E, Zara F, Avanzini G, Franceschetti S, Mantegazza M, Effects in neocortical neurons of mutations of the Na(v)1.2 Na+ channel causing benign familial neonatal-infantile seizures., J Neurosci 2006 Oct; 26(40): 10100-9.
2006
Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA, Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy., Nat Neurosci 2006 Sep; 9(9): 1142-9.
2005
Mantegazza M, Gambardella A, Rusconi R, Schiavon E, Annesi F, Cassulini RR, Labate A, Carrideo S, Chifari R, Canevini MP, Canger R, Franceschetti S, Annesi G, Wanke E, Quattrone A, Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures., Proc Natl Acad Sci U S A 2005 Dec; 102(50): 18177-82.
2005
Mantegazza M, Cestèle S, Beta-scorpion toxin effects suggest electrostatic interactions in domain II of voltage-dependent sodium channels., J Physiol 2005 Oct; 568(Pt 1): 13-30.
2005
Srairi-Abid N, Guijarro JI, Benkhalifa R, Mantegazza M, Cheikh A, Ben Aissa M, Haumont PY, Delepierre M, El Ayeb M, A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels., Biochem J 2005 Jun; 388(Pt 2): 455-64.
2005
Mantegazza M, Yu FH, Powell AJ, Clare JJ, Catterall WA, Scheuer T, Molecular determinants for modulation of persistent sodium current by G-protein betagamma subunits., J Neurosci 2005 Mar; 25(13): 3341-9.
2004
M'Barek S, Fajloun Z, Cestèle S, Devaux C, Mansuelle P, Mosbah A, Jouirou B, Mantegazza M, Van Rietschoten J, El Ayeb M, Rochat H, Sabatier JM, Sampieri F, First chemical synthesis of a scorpion alpha-toxin affecting sodium channels: the Aah I toxin of Androctonus australis hector., J Pept Sci 2004 Nov; 10(11): 666-77.
2004
Curia G, Aracri P, Sancini G, Mantegazza M, Avanzini G, Franceschetti S, Protein-kinase C-dependent phosphorylation inhibits the effect of the antiepileptic drug topiramate on the persistent fraction of sodium currents., Neuroscience 2004 ; 127(1): 63-8.
2001
Mantegazza M, Yu FH, Catterall WA, Scheuer T, Role of the C-terminal domain in inactivation of brain and cardiac sodium channels., Proc Natl Acad Sci U S A 2001 Dec; 98(26): 15348-53.
2001
Cestèle S, Scheuer T, Mantegazza M, Rochat H, Catterall WA, Neutralization of gating charges in domain II of the sodium channel alpha subunit enhances voltage-sensor trapping by a beta-scorpion toxin., J Gen Physiol 2001 Sep; 118(3): 291-302.
1999
Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G, Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate., J Pharmacol Exp Ther 1999 Mar; 288(3): 960-8.
1998
Taverna S, Mantegazza M, Franceschetti S, Avanzini G, Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons., Epilepsy Res 1998 Sep; 32(1-2): 304-8.
1998
Mantegazza M, Franceschetti S, Avanzini G, Anemone toxin (ATX II)-induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones., J Physiol 1998 Feb; 507 ( Pt 1)(Pt 1): 105-16.
1998
Magistretti J, Mantegazza M, de Curtis M, Wanke E, Modalities of distortion of physiological voltage signals by patch-clamp amplifiers: a modeling study., Biophys J 1998 Feb; 74(2 Pt 1): 831-42.
1996
Magistretti J, Mantegazza M, Guatteo E, Wanke E, Action potentials recorded with patch-clamp amplifiers: are they genuine?, Trends Neurosci 1996 Dec; 19(12): 530-4.
1995
Mantegazza M, Fasolato C, Hescheler J, Pietrobon D, Stimulation of single L-type calcium channels in rat pituitary GH3 cells by thyrotropin-releasing hormone., EMBO J 1995 Mar; 14(6): 1075-83.
1994
Wanke E, Bianchi L, Mantegazza M, Guatteo E, Mancinelli E, Ferroni A, Muscarinic regulation of Ca2+ currents in rat sensory neurons: channel and receptor types, dose-response relationships and cross-talk pathways., Eur J Neurosci 1994 Mar; 6(3): 381-91.